State of Wyoming’s Haemonetics HAE Stock Holding History

State of Wyoming’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$261K	Sell	3,475 -1,759	-34%	-$113K	0.03%	795
2026 Q1	$295K	Buy	5,234 +2,485	+90%	+$162K	0.04%	678
2025 Q4	$220K	Buy	+2,749	New	+$185K	0.02%	894
2024 Q2	–	Sell	-567	Closed	-$48.4K	–	1748
2024 Q1	$48.4K	Buy	+567	New	+$44.5K	0.01%	1306
2023 Q3	–	Sell	-161	Closed	-$13.7K	–	1703
2023 Q2	$13.7K	Sell	161 -1,172	-88%	-$99.1K	﹤0.01%	1456
2023 Q1	$110K	Buy	1,333 +981	+279%	+$79.4K	0.04%	720
2022 Q4	$27.7K	Buy	+352	New	+$28.3K	0.01%	1269
2022 Q2	–	Sell	-317	Closed	-$20K	–	1984
2022 Q1	$20K	Buy	317 +86	+37%	+$4.68K	0.01%	1434
2021 Q4	$12K	Buy	+231	New	+$14.1K	0.01%	1645

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's HAE Position: Q2 2026 in Review

State of Wyoming reduced its Haemonetics (HAE) stake by 34% in Q2 2026, selling an estimated $113K and leaving 3,475 shares worth $261K. The position accounts for 0.03% of the portfolio, ranked #795.

State of Wyoming first reported a position in HAE in Q4 2021 and has held it in 9 quarters since. The position peaked at $295K in Q1 2026. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

State of Wyoming held 3,475 shares of Haemonetics worth $261K as of Q2 2026.
State of Wyoming sold 1,759 Haemonetics shares in Q2 2026, an estimated $113K.
Haemonetics made up 0.03% of State of Wyoming's portfolio in Q2 2026, its #795 holding.
State of Wyoming first reported a position in Haemonetics in Q4 2021 and has held it in 9 quarters since.
State of Wyoming's Haemonetics position peaked at $295K in Q1 2026.
330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.